ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitis

NCT03645057 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Crisaborole
DRUG: Tacrolimus 0.03% Ointment

Sponsor

University of Rochester